AbbVie Inc. Files 8-K on Financials
Ticker: ABBV · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1551152
| Field | Detail |
|---|---|
| Company | Abbvie Inc. (ABBV) |
| Form Type | 8-K |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k
Related Tickers: ABBV
TL;DR
ABBV filed an 8-K on 4/25/25 detailing financial results. Check it out.
AI Summary
AbbVie Inc. filed an 8-K on April 25, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's business. AbbVie Inc. is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This 8-K filing provides crucial updates on AbbVie's financial performance and condition, which is essential for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial results and does not indicate any unusual risks or events.
Key Players & Entities
- AbbVie Inc. (company) — Registrant
- April 25, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 32-0375147 (ein) — Employer Identification Number
FAQ
What is the primary purpose of this 8-K filing for AbbVie Inc.?
The primary purpose of this 8-K filing is to report on AbbVie Inc.'s Results of Operations and Financial Condition, and it includes Financial Statements and Exhibits.
On what date was this 8-K report filed or as of what date is it effective?
The report is dated April 25, 2025, and is the date of the earliest event reported.
In which U.S. state is AbbVie Inc. incorporated?
AbbVie Inc. is incorporated in Delaware.
What is AbbVie Inc.'s Employer Identification Number (EIN)?
AbbVie Inc.'s EIN is 32-0375147.
What is AbbVie Inc.'s fiscal year end?
AbbVie Inc.'s fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding AbbVie Inc. (ABBV).